<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005200A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005200</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14002169</doc-number><date>20120209</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>11156463.9</doc-number><date>20110301</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514249</main-classification><further-classification>544350</further-classification></classification-national><invention-title id="d0e61">6,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-4-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Trabanco-Su&#xe1;rez</last-name><first-name>Andr&#xe9;s Avelino</first-name><address><city>Toledo</city><country>ES</country></address></addressbook><residence><country>ES</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Gijsen</last-name><first-name>Henricus Jacobus Maria</first-name><address><city>Beerse</city><country>BE</country></address></addressbook><residence><country>BE</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Van Gool</last-name><first-name>Michiel Luc Maria</first-name><address><city>Toledo</city><country>ES</country></address></addressbook><residence><country>ES</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Vega Ramiro</last-name><first-name>Juan Antonio</first-name><address><city>Toledo</city><country>ES</country></address></addressbook><residence><country>ES</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Delgado-Jim&#xe9;nez</last-name><first-name>Francisca</first-name><address><city>Toledo</city><country>ES</country></address></addressbook><residence><country>ES</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Trabanco-Su&#xe1;rez</last-name><first-name>Andr&#xe9;s Avelino</first-name><address><city>Toledo</city><country>ES</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Gijsen</last-name><first-name>Henricus Jacobus Maria</first-name><address><city>Beerse</city><country>BE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Van Gool</last-name><first-name>Michiel Luc Maria</first-name><address><city>Toledo</city><country>ES</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Vega Ramiro</last-name><first-name>Juan Antonio</first-name><address><city>Toledo</city><country>ES</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Delgado-Jim&#xe9;nez</last-name><first-name>Francisca</first-name><address><city>Toledo</city><country>ES</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Janssen Pharmaceutica NV</orgname><role>03</role><address><city>Beerse</city><country>BE</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/EP2012/053455</doc-number><kind>00</kind><date>20120209</date></document-id><us-371c124-date><date>20130829</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to novel 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-yl-amine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid.</p></abstract></us-patent-application>